That's my point. APT's ongoing marketing & communications is its strength. Is its product offering really that unique.....my answer is "No" IMO.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago